Healthcare Sector Recap; Boston Scientific (BSX) Plans to Lower 1000 Jobs while Eli Lilly (LLY) Profit Tumble – BSX, LLY, PFE, KERX, RPRX, SNTA

Last trading session data confirmed that healthcare sector reacted positively with +0.99% change. Keryx Biopharmaceuticals (NASDAQ:KERX) and Repros Therapeutics Inc (NASDAQ:RPRX) were major percentage gainers in this sector while key decliner was Synta Pharmaceuticals Corp (NASDAQ:SNTA).

The Natick, Massachusetts- based Boston Scientific Corporation (NYSE:BSX) aims to lower almost 1,000 employments in an expansion of its revamping plan that will save one more $100 million to $115 million per year.

Boston Scientific, the second- biggest manufacturer of heart devices, reported in a statement that it will merge attrition and headcount reductions in the cost-reduction plan. The company also announced fiscal Q4 net income plunged 44% to $60 million or 4 cents per share. Revenue plunged 1.5% to $1.82 billion.

Boston Scientific Corporation’s YTD performance was recorded as 23.91% while its market capitalization was $9.75 billion. The company has P/B ratio of 1.43. Institutional ownership owns 86.59% shares of the company while beta factor, which is used to measure riskiness of the security, was 1.12. Net profit margin of the company was -55.27% while its gross profit margin was 66.80%.

Eli Lilly & Co (NYSE:LLY) announced that fiscal Q4 earnings plunged 3.6% as the drug manufacturer booked weaker revenue as sales of its antipsychotic, Zyprexa, plunge.

Eli Lilly & Co. has market capitalization of $63.03 billion. Its current ratio was 2.02 while its shares were looking forward SMA50 with 8.80. The company offered earnings per share of 3.68 while its 1.16 billion shares were outstanding. YTD performance of the stock was 10.14%.

Pfizer Inc. (NYSE:PFE) has the market capitalization of $203.94 billion. The company’s EPS was 1.25 while its 7.36 billion shares were outstanding. Its institutional ownership was 72.92%. Shares of the company were moving ahead of SMA50 with 8.61% while its YTD performance was 10.45%.

DO NOT TRADE ANY STOCK WITHOUT LEVEL 2 STOCK QUOTES! delivers it's user with the most in-depth Level 2 Quotation System available on the Planet! NO Downloads, NO Widgets, NO Plugins required! Stay on TOP of your trades with! CLICK HERE TO START YOUR FREE 30-DAY TRIAL

This entry was posted in Healthcare, Latest Headlines and tagged , , , , , , , , , , , , , , , , , . Bookmark the permalink.